Cordycepin, derived from fungi, shows promise in cancer therapy by inhibiting growth factor signaling pathways critical for ...

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq ...

The CNIPA invalidated the Patent on the ground that the claims lack inventiveness over the combination of Evidence 6, ...